GlassScriptPhysician profile
Brooks D Cash
NPI 1114920626
$866,534.58
in general payments reported to CMS, 2019-2025
43 companies · $90K in 2025
The $90K reported for 2025 was more than what 99% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100K · 2020: $105K · 2021: $131K · 2022: $117K · 2023: $154K · 2024: $170K · 2025: $90K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $230K · Consulting Fee: $84K · Honoraria: $42K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $27K · Travel and Lodging: $20K · Food and Beverage: $8,904 · Education: $3,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $229,512.56 |
| Consulting Fee | $83,948.00 |
| Honoraria | $41,900.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $26,517.38 |
| Travel and Lodging | $19,575.02 |
| Food and Beverage | $8,903.51 |
| Education | $3,513.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135,505.83 | 2019-2025 | Xifaxan, Trulance |
| Ardelyx, INC. | $87,722.40 | 2022-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $85,281.04 | 2023-2025 | Voquezna, Voquezna Dual Pak, Voquezna Triple Pak |
| Qol Medical, LLC | $74,071.65 | 2019-2025 | Sucraid, Sucraid |
| Alnylam Pharmaceuticals INC. | $68,539.01 | 2019-2025 | Givlaari, Amvuttra |
| Takeda Pharmaceuticals U.S.A., INC. | $56,940.88 | 2020-2021 | |
| Medtronic, INC. | $50,507.29 | 2021-2025 | Endoflip |
| Regeneron Healthcare Solutions, INC. | $45,907.01 | 2022-2025 | Dupixent |
| Abbvie INC. | $41,196.75 | 2020-2025 | Linzess, Viberzi, Rinvoq |
| Genzyme Corporation | $29,319.08 | 2023-2025 | |
| Shire North American Group INC | $26,034.21 | 2019 | |
| Redhill Biopharma INC. | $24,880.20 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $22,266.74 | 2023-2024 | Andexxa |
| Pfizer INC. | $17,361.91 | 2019-2025 | |
| Covidien LP | $14,843.13 | 2020 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $12,638.50 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $12,075.00 | 2021-2022 | |
| Allergan, INC. | $10,796.22 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $9,186.75 | 2019 | |
| Sebela Pharmaceuticals INC. | $6,900.00 | 2020-2022 | |
| Napo Pharmaceuticals INC | $6,892.38 | 2025 | Mytesi |
| Alfasigma USA, INC. | $5,835.02 | 2020 | |
| Azurity Pharmaceuticals, INC. | $5,700.00 | 2025 | |
| Iterative Scopes, INC. | $2,799.00 | 2023-2024 | Skout, Skout System |
| Celltrion USA INC. | $2,500.00 | 2025 | Zymfentra |
| Olympus Corporation | $2,160.50 | 2021-2023 | Evis Exera III Video System Center |
| Astrazeneca Ab | $2,148.00 | 2023-2024 | Andexxa |
| Olympus Medical Systems Corporation | $1,240.00 | 2024 | |
| Mauna Kea Technologies, INC. | $1,000.00 | 2021 | |
| Aries Pharmaceuticals, INC. | $974.10 | 2019 | |
| Eli Lilly and Company | $800.00 | 2025 | Omvoh |
| Pentax of America, INC. | $653.67 | 2022 | |
| Vibrant Gastro, INC. | $617.88 | 2023-2024 | Vibrant Starter Kit |
| Conmed Corporation | $366.18 | 2024-2025 | Conmed Generators, Conmed Biliary |
| Enterra Medical, INC. | $158.38 | 2025 | |
| Boston Scientific Corporation | $153.62 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $124.49 | 2019 | |
| Erbe USA INC | $115.98 | 2019 | |
| Janssen Biotech, INC. | $99.00 | 2024 | Stelara |
| Mahana Therapeutics, INC. | $86.76 | 2021-2022 | |
| Anx Robotica Corp | $75.85 | 2022 | |
| Nestle Healthcare Nutrition INC. | $39.23 | 2022 | |
| Gilead Sciences, INC. | $20.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooks Cash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.